The Securities and Exchange Commission today charged Mark Schena, the President and Chief Science Officer of Arrayit Corporation, for making allegedly false and misleading statements concerning Arrayit’s development of a COVID-19 blood test and its… Article source: https://www.sec.gov/news/press-release/2020-224
